Relationship between Retinopathy and Cognitive Impairment among Hypertensive Subjects

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Neurology

• Publication date

  2004-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000081855PMID 15528916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertensive Retinopathy

  2020cited by this paper
• [Cognitive decline and hypertension].

  2003cited by this paper
• Hypertension and dementia

  2003cited by this paper
• Transient ischaemic attacks are associated with increased rates of global cerebral atrophy

  2003cited by this paper
• Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

  2003cited by this paper
• Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population

  2003cited by this paper
• Antihypertensive drugs and cognitive function

  2002cited by this paper
• Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans.

  2002cited by this paper
• Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data.

  2002cited by this paper
• Office management of elderly hypertensive patients. Focusing on cognition and function.

  2001cited by this paper
• [Cerebral complications of hypertension in the elderly].

  2001cited by this paper
• Les complications cérébrales de l'hypertension artérielle chez le sujet âgé

  2001cited by this paper
• Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

  2001cited by this paper
• [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].

  2001cited by this paper
• Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension.

  2001cited by this paper
• Understanding the Diagnostic Capabilities of Cognitive Tests

  2001cited by this paper
• Hypertension and dementia

  2001cited by this paper
• [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].

  2001cited by this paper
• [Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication].

  2000cited by this paper
• Cognitief functieverlies en dementie bij bloeddrukverhoging; het effect van bloeddrukverlagende medicatie

  2000cited by this paper
• [Cognitive impairment and dementia in hypertension; the effect of antihypertensive agents].

  2000cited by this paper
• The Association Between Vascular Risk Factor‐Mediating Medications and Cognition and Dementia Diagnosis in a Community‐Based Sample of African‐Americans

  2000cited by this paper
• Behavioural parameters in hypertensives on atenolol therapy.

  1999cited by this paper
• Effects of hypertension and its treatment on mental function

  1999cited by this paper
• [Antihypertensive treatment and prevention of dementia].

  1999cited by this paper
• Association of midlife blood pressure to late-life cognitive decline and brain morphology

  1998cited by this paper
• Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure

  1998cited by this paper
• Blood pressure and intellectual function in elderly subjects.

  1997cited by this paper
• Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project.

  1997cited by this paper
• The Mini-Mental State Examination in general medical practice: clinical utility and acceptance.

  1996cited by this paper
• Population-based norms for the Mini-Mental State Examination by age and educational level.

  1993cited by this paper
• Retinal changes in malignant hypertension.

  1986cited by this paper
• RENAL CHANGES IN MALIGNANT HYPERTENSION

  1939cited by this paper

• RAVIR: A Dataset and Methodology for the Semantic Segmentation and Quantitative Analysis of Retinal Arteries and Veins in Infrared Reflectance Imaging

  2022cites this paper
• White Matter Hyperintensities of Bilateral Lenticular Putamen in Patients with Proliferative Diabetic Retinopathy: A Voxel‐based Morphometric Study

  2021cites this paper
• Brain metabolite alterations demonstrated by proton magnetic resonance spectroscopy in diabetic patients with retinopathy.

  2014cites this paper
• Retinopathy and cognitive impairment in adults with CKD.

  2013cites this paper
• Associations Between Retinal Microvascular Changes and Dementia, Cognitive Functioning, and Brain Imaging Abnormalities: A Systematic Review

  2013cites this paper
• Retinal microvascular abnormalities and cognitive function in older people with type 2 diabetes

  2010cites this paper
• 15-year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons.

  2010cites this paper
• Retinal Microvascular Signs and Cognitive Impairment

  2009cites this paper
• Diabetic retinopathy and systemic vascular complications.

  2008cites this paper
• Retinal microvascular abnormalities and cognitive dysfunction: a systematic review

  2008cites this paper
• Diabetic Retinopathy and Systemic Complications

  2008cites this paper
• Endocrine mucin‐producing sweat gland carcinoma: report of a case and review of the literature

  2006cites this paper
• The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study.

  2006cites this paper
• Hypertensive retinopathy revisited: some answers, more questions

  2005cites this paper
• Isohumulones, Bitter Acids Derived from Hops, Activate Both Peroxisome Proliferator-activated Receptor α and γ and Reduce Insulin Resistance*

  2004cites this paper
• Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance.

  2004cites this paper